| # | Drug | Count |
|---|---|---|
| 0 | CARBOPLATIN | 23 |
| 1 | DOXORUBICIN | 20 |
| 2 | DEXAMETHASONE | 19 |
| 3 | DEXAMETHASONE 1.5 MG | 19 |
| 4 | FULVESTRANT | 18 |
| 5 | GEMCITABINE HYDROCHLORIDE | 18 |
| 6 | BEVACIZUMAB | 17 |
| 7 | PALBOCICLIB | 17 |
| 8 | GEMCITABINE | 16 |
| 9 | METFORMIN | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE | 1 | 0.0227 |
| 1 | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | 1 | 0.0040 |
| 2 | CARMUSTINE | 11 | 0.0023 |
| 3 | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | 1 | 0.0023 |
| 4 | VANCOMYCIN HYDROCHLORIDE | 11 | 0.0013 |
| 5 | BLINATUMOMAB | 12 | 0.0011 |
| 6 | BENDAMUSTINE HYDROCHLORIDE | 9 | 0.0011 |
| 7 | IXABEPILONE | 1 | 0.0010 |
| 8 | SODIUM FLUORIDE AND POTASSIUM NITRATE | 1 | 0.0010 |
| 9 | ALDESLEUKIN | 1 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 41 |
| 1 | Kinase Inhibitor [EPC] | 39 |
| 2 | Platinum-based Drug [EPC] | 30 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 25 |
| 4 | Alkylating Drug [EPC] | 19 |
| 5 | Estrogen Receptor Antagonist [EPC] | 18 |
| 6 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 17 |
| 7 | Aromatase Inhibitor [EPC] | 15 |
| 8 | Microtubule Inhibitor [EPC] | 14 |
| 9 | mTOR Inhibitor Immunosuppressant [EPC] | 13 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 1 | Estrogen Receptor Antagonist [EPC] | 18 | 0.0004 |
| 2 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 8 | 0.0004 |
| 3 | Oxazolidinone Antibacterial [EPC] | 9 | 0.0003 |
| 4 | Autologous Cellular Immunotherapy [EPC] | 1 | 0.0002 |
| 5 | Epidermal Growth Factor Receptor Antagonist [EPC] | 8 | 0.0002 |
| 6 | Glycopeptide Antibacterial [EPC] | 11 | 0.0002 |
| 7 | Aromatase Inhibitor [EPC] | 15 | 0.0001 |
| 8 | Topoisomerase Inhibitor [EPC] | 10 | 0.0001 |
| 9 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 11 | 0.0001 |